Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
AMEX
Gentium Spa Ads (GNT)
Gentium Spa Ads (GNT) News

Gentium Spa (GNT)

Gentium Spa Ads

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:GNT

1

Date	Time	Source	Headline	Symbol	Company
16/05/2006	13:00	Business Wire	Gentium Begins Trading on NASDAQ; New Ticker Symbol: GENT	AMEX:GNT	Gentium Spa Ads
05/05/2006	13:42	Business Wire	Gentium to Trade on NASDAQ National Market	AMEX:GNT	Gentium Spa Ads
13/04/2006	11:00	Business Wire	Gentium Reports 2005 Financial Results; Provides Financial and Clinical Update	AMEX:GNT	Gentium Spa Ads
28/03/2006	14:00	Business Wire	Gentium Receives First IRB Approval to Begin U.S. Phase III Trial with Defibrotide to Treat Veno-Occlusive Disease with Multipl	AMEX:GNT	Gentium Spa Ads
02/02/2006	13:00	Business Wire	Gentium to Present at Angiogenesis in Cancer and Vascular Disease Congress; Defibrotide Has Anti-Angiogenic Properties In Vitro	AMEX:GNT	Gentium Spa Ads
30/01/2006	13:00	Business Wire	Gentium's Defibrotide Subject of Independent Study in Japan; First Japanese Study Reports That Defibrotide Shows Success Treatin	AMEX:GNT	Gentium Spa Ads
20/01/2006	12:30	Business Wire	Gentium Initiates Phase II/III Pediatric Trial with Defibrotide to Prevent Veno-Occlusive Disease; European Group for Blood and	AMEX:GNT	Gentium Spa Ads
15/11/2005	12:00	Business Wire	Gentium Reports Third Quarter Financial Results; Provides Financial and Clinical Update	AMEX:GNT	Gentium Spa Ads
07/11/2005	15:12	Business Wire	Gentium to Present at Rodman & Renshaw Techvest Seventh Annual Healthcare Conference	AMEX:GNT	Gentium Spa Ads
17/10/2005	11:00	Business Wire	Gentium Completes $10.9 Million Private Placement	AMEX:GNT	Gentium Spa Ads
04/10/2005	14:23	Business Wire	Gentium Raises $10.9 Million in Private Offering; Funding to Support New Trials and Continued Development of Pipeline	AMEX:GNT	Gentium Spa Ads
21/09/2005	11:00	Business Wire	Gentium S.p.A. Announces Initiation of Independent Phase I/II Study of Defibrotide to treat Multiple Myeloma	AMEX:GNT	Gentium Spa Ads
15/09/2005	09:00	Business Wire	Renowned Bone Marrow Transplantation Expert Richard E. Champlin, M.D., Joins Gentium's Scientific Advisory Board	AMEX:GNT	Gentium Spa Ads
07/09/2005	09:00	Business Wire	Gentium S.p.A. Announces Intention to Commence Phase III Trial Following Discussions with FDA	AMEX:GNT	Gentium Spa Ads
10/08/2005	09:00	Business Wire	Gentium Reports Second Quarter Financial Results, Provides Clinical Update	AMEX:GNT	Gentium Spa Ads
09/08/2005	09:00	Business Wire	Gentium Presented Laboratory Data at XXth Congress of International Society for Thrombosis and Haemostasis; Laboratory Data Pres	AMEX:GNT	Gentium Spa Ads
13/07/2005	21:05	Business Wire	Gentium S.p.A. Announces FDA Agrees Company's CMC Submission is Adequate for Commencing Phase III Clinical Trials with Defibroti	AMEX:GNT	Gentium Spa Ads
16/06/2005	23:10	PR Newswire (US)	American Stock Exchange Lists American Depository Shares Representing Ordinary Shares Of Gentium S.p.A	NYSE:GNT
16/06/2005	17:38	PR Newswire (US)	Gentium S.p.A. Announces Pricing of Initial Public Offering	NYSE:GNT

Showing the most relevant articles for your search:AMEX:GNT

1

GigaCloud Technology

Sigma Fin.frn12

FRX Innovations

Banque France 3875% 23/26

Ferro-alloy Resources

BNP Paribas Issuance

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions